Ben Mcgraw

Dr. McGraw is Chairman and CEO of TheraVida, Inc., a specialty pharmaceutical company, as well as Executive Chairman of Auration Biotech, Inc., a private biotechnology company focused on using growth factors for tissue regeneration. He is the lead independent director for the board of Aerie Pharmaceuticals, a public ophthalmology company, and is active in the SPARK program at Stanford University. Previously, Dr. McGraw was on the board of Ista Pharmaceuticals, a public ophthalmology company, Chairman and CEO of Valentis, Inc., Corporate Vice President, Corporate Development at Allergan, Inc., and Vice President, Development at Marion Laboratories, Inc. and Marion Merrell Dow, Inc. (now Sanofi US). Dr. McGraw received his B.S. and Doctor of Pharmacy degrees from the University of Tennessee Health Science Center, where he also completed a clinical practice residency.